No Data
No Data
Why Amphastar (AMPH) Is Poised to Beat Earnings Estimates Again
With this earnings history in mind, recent estimates have been moving higher for Amphastar.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
BofA Securities Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating
BofA Securities analyst Jason Gerberry maintains $Amphastar Pharmaceuticals(AMPH.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 44.4% and a total average
Bank of America Securities Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...
No Data